Cytodyn Inc (CYDY)

[Blane]

Because some are looking for a quick buyout and some are looking for a return on their investment that matches the magnitude of what we have. I don’t think it’s about capability anymore. I think it’s about low ball pressures from outside companies, and inside shareholders, who think this drug should sell for cheap just to satisfy a call to sell... right when the momentum is about ramp up.

Red tape, clout, low ball offers.... data is coming, more people are getting treated for their Covid, and every biotech company started small. I’m actually proud of Nader for what he did. He can always take a buyout later if necessary, but he wasn’t about to do it right now at such a critical juncture. Think about that.